Partnership
Harvard University x Kyowa Kirin
Harvard University's Office of Technology Development established a five-year strategic research alliance with Kyowa Kirin to advance innovation in therapeutics and biomedical technology platforms. The alliance fuels scientific collaboration among academic and industry researchers to translate discoveries into meaningful patient benefits.
development · Active · just announced
Machine-readable surfaces
- Markdown mirror: /partnerships/harvard-university-x-kyowa-kirin.md
- JSON-LD: embedded in this page’s head
- REST API: /v1/partnerships/harvard-university-x-kyowa-kirin
- Revision history: /partnerships/harvard-university-x-kyowa-kirin/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
44447d1c-9f86-4949-9530-b074edcdd5fa- Type
- development
- Status
- Activejust announced
Who’s involved
Private Ivy League research university in Cambridge, Massachusetts, founded 1636. Robotics research spans the Wyss Institute for Biologically Inspired Engineering, Harvard Microrobotics Laboratory, and Self-organizing Systems Research Group. Notable contributions include the RoboBee micro-robot, [Soft robotics](/companies/soft-robotics-inc), and swarm robotics.
Off-registry parties
- Kyowa Kirin · co developer
Related partnerships
Other deals between the same parties
- technology—operating
- technology—operating
Other partnerships of Harvard University
- technology—operating
- technology—operating
Recent partnerships of the same kind
- Kautex Textron RESiLiTE Horizon EuropeKautex Textron + Horizon Europe EU Programmedevelopment—operating
- Canvas x USG CorporationCanvas + USG Corporationdevelopment—operating
- Threod Systems x First ShieldFirst Shield + Threod Systemsdevelopment—operating
- RIKEN BDR x Otsuka Pharmaceutical CollaborationRIKEN Center for Biosystems Dynamics + Otsuka Pharmaceuticaldevelopment—operating
- Entegris x SEMATECHEntegris + SEMATECHdevelopment—operating
- development—operating
Sources (1)
Deploy Watch
Track this partnership.
We notify you when the status changes against primary-source evidence, expansion is verified, or the partnership is terminated.